SEP 09, 2021 6:00 AM PDT

A Drug Test for Synthetic Cannabis Use

WRITTEN BY: Tara Fernandez

Designer drugs are synthetic analogs of prohibited substances such as cocaine and LSD made in clandestine laboratories and devised to circumvent legislative bans against such narcotics. Synthetic cannabinoids, for instance, are rapidly metabolized once taken by a user and are not detectable using standard urine testing protocols.

In a new study, researchers have turned to science for solutions to support the surveillance of designer drug abuse in the community. Pharmacy experts have come up with a panel of four novel urine biomarkers that can be used by testing agencies to alert to the consumption of ADB-BUTINACA, an emerging synthetic psychoactive substance.

Up to now, forensics specialists have been challenged by the steady emergence of novel synthetic cannabinoids such as ADB-BUTINACA, a molecule first identified in Europe around 2019 that is known to cause psychoactive effects similar to delta-9-tetrahydrocannabinol (THC), the active ingredient in marijuana. Conventional methods of detecting ADB-BUTINACA use are relatively laborious and time-consuming compared to other drug-testing methods.

The research team hypothesized that identifying signature metabolites of the synthetic cannabinoid in urine samples using established drug metabolism and pharmacokinetics principles may offer a solution. The team created a library of the primary ADB-BUTINACA metabolites in the laboratory to test their theory, using human liver enzymes. Their analysis revealed 15 key ADB-BUTINACA metabolites produced in the body and excreted in the urine, four of which represent biomarkers to diagnose the consumption of the drug.

Follow-up studies are zeroing in on the biological mechanisms governing the kidneys' excretion of these novel metabolites to further fine-tune a potential urine test for ADB-BUTINACA.
 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 05, 2021
Technology
Portable Sensor Could Help Diagnosis Heart Attacks Quickly
OCT 05, 2021
Portable Sensor Could Help Diagnosis Heart Attacks Quickly
According to the Centers for Disease Control, someone in the U.S. has a heart attack about every 40 seconds. Despite bei ...
OCT 14, 2021
Clinical & Molecular DX
Cancer-Sniffing Worms: The Future of Diagnostics?
OCT 14, 2021
Cancer-Sniffing Worms: The Future of Diagnostics?
Researchers have unlocked a way of sniffing out cancer in patients with very-early-stage pancreatic cancer. This time, i ...
NOV 11, 2021
Cancer
US Military Veterans: Cancer Risk and Cancer Research
NOV 11, 2021
US Military Veterans: Cancer Risk and Cancer Research
The US Department of Veteran’s Affairs (VA) estimates about 50,000 new cancer cases diagnosed each year. In total, ...
DEC 01, 2021
Cardiology
Is GDF-15 a Valuable Biomarker for Congestive Heart Failure?
DEC 01, 2021
Is GDF-15 a Valuable Biomarker for Congestive Heart Failure?
Congestive Heart Failure (CHF) is a serious medical condition that results in the heart not being able to pump to meet t ...
DEC 23, 2021
Cannabis Sciences
Acute Intoxication Effects of Legal-Market High-Potency THC-Enriched vs. CBD-Enriched Cannabis Concentrates
DEC 23, 2021
Acute Intoxication Effects of Legal-Market High-Potency THC-Enriched vs. CBD-Enriched Cannabis Concentrates
Researchers from Colorado State University and the University of Colorado Boulder have just released the first study to ...
JAN 05, 2022
Clinical & Molecular DX
Labroots 2021 Clinical Research & Diagnostics Virtual Event's Winning Poster
JAN 05, 2022
Labroots 2021 Clinical Research & Diagnostics Virtual Event's Winning Poster
The SARS-CoV-2 virus that emerged in December 2019 causes the disease COVID-19, a pandemic that has killed over 5 millio ...
Loading Comments...